Welcome to LookChem.com Sign In|Join Free
The company logo of Chemvon Biotechnology Co. Ltd.

Chemvon Biotechnology Co. Ltd.

Assessed Supplier Enterprise Certification

Assessed
Supplier
16th
years

Chemvon Biotechnology Co. Ltd.

Business Type:Lab/Research institutions

Audited Supplier

Main Products:
Atocalcitol ,Inecalcitol,Alvimopan ,Fosaprepitant, Bimatoprost,Lubiprostone,Tafluprost
Year Established:
2008
Home>>Products>>Tafluprost

Product Certification&
Enterprise Certification

More Detail

Chemvon Biotechnology Co. Ltd.

Country: China (Mainland)

Business Type:Lab/Research institutions

Mr.peter

Tel: 86-21-58550039;86-21-31268550-8004

Mobile:

Tel: 86-21-58550039;86-21-31268550-8004

Fax: 86-21-50790419

URL: http://www.chemvon.com

Province/state: shanghai

City: shanghai

Street: Suite B-10#, 6999 Chuansha Road, Pudong District, Shanghai 201202, China

MaxCard:


Contact Suppliers

Tafluprost

CAS NO.209860-87-7

  • Min.Order: 1 Gram
  • Payment Terms:
Contact Supplier

Product Details

Keywords

  • Tafluprost manufacturer

Quick Details

  • ProName: Tafluprost
  • CasNo: 209860-87-7
  • Molecular Formula: C25H34F2O5
  • Port: any port in China
  • ProductionCapacity: Metric Ton/Day
  • Purity: 99
  • Transportation: as requested
  • LimitNum: 1 Gram
  • Grade: Pharma Grade

Superiority

Chemvon Biotechnology is one of the leading high-technology manufacturer in the field of pharmaceutical and fine chemical industry.

From origins as a research group in technology service, chemvon has progressed into an integrated company with a kilo lab and a pilot plant offering a range of APIs, NCEs and some organic intermediates.

Tafluprost is our regular products. 

Details

Name : Tafluprost 

 Synonyms:  (5Z)-7-[(1R,2R,3R,5S)-2-[(1E)-3,3-Difluoro-4-phenoxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-5-heptenoic acid 1-methylethyl ester 

 Molecular Formula : C25H34F2O5 

 Molecular Weight : 452.53  

CAS Registry Number :  209860-87-7

Tafluprost: is a prostaglandin analogue used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. It reduces intraocular pressure by increasing the outflow of aqueous fluid from the eyes.

无标题页